PRVA
Privia Health Group Inc
$
25.020
- Overview
- Forecast
- Valuation
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
25.220
Open
24.910
VWAP
25.02
Vol
708.33K
Mkt Cap
3.05B
Low
24.833
Amount
17.72M
EV/EBITDA(TTM)
75.37
Total Shares
119.32M
EV
2.63B
EV/OCF(TTM)
22.23
P/S(TTM)
1.75
Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improve patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The platform supports multiple provider types, enables scalable operations, and delivers patient centric in-person and virtual access to care, quality metrics, and lower cost of care. It provides management services to each Medical Group though a local management services organization.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
488.04M
+5.89%
--
--
474.13M
+8.27%
--
--
466.36M
+10.43%
--
--
Estimates Revision
The market is revising Upward the revenue expectations for Privia Health Group, Inc. (PRVA) for FY2025, with the revenue forecasts being adjusted by 0.78% over the past three months. During the same period, the stock price has changed by -0.08%.
Revenue Estimates for FY2025
Revise Upward
+0.78%
In Past 3 Month
Stock Price
Go Down
-0.08%
In Past 3 Month
18 Analyst Rating
19.66% Upside
Wall Street analysts forecast PRVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRVA is 29.94 USD with a low forecast of 23.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
17 Buy
1 Hold
0 Sell
Strong Buy
19.66% Upside
Current: 25.020
Low
23.00
Averages
29.94
High
40.00
19.66% Upside
Current: 25.020
Low
23.00
Averages
29.94
High
40.00
JMP Securities
Constantine Davides
Buy
Reiterates
$29
2025-04-28
Reason
JMP Securities
Constantine Davides
Price Target
$29
2025-04-28
Reiterates
Buy
Reason
Baird
Michael Ha
Buy
Maintains
$24 → $26
2025-04-15
Reason
Baird
Michael Ha
Price Target
$24 → $26
2025-04-15
Maintains
Buy
Reason
Baird analyst Michael Ha raised the firm's price target on Privia Health to $26 from $24 and keeps an Outperform rating on the shares. The firm sees minimal incremental buyers of stocks in the managed care and healthcare facilities group until the policy overhang clears. Baird does not not expect guidance raises as it believes companies will maintain 2025 "conservatism and cushion" given potential Part D and macro headwinds that may evolve later this year.
Needham
Matthew Sheerin
Strong Buy
Reiterates
$30
2025-04-10
Reason
Needham
Matthew Sheerin
Price Target
$30
2025-04-10
Reiterates
Strong Buy
Reason
Truist Securities
Jailendra Singh
Strong Buy
Maintains
$27 → $28
2025-04-10
Reason
Truist Securities
Jailendra Singh
Price Target
$27 → $28
2025-04-10
Maintains
Strong Buy
Reason
Truist lowered the firm's price target on Privia Health to $28 from $30 and keeps a Buy rating on the shares as part of a broader research note previewing Q1 results in the Healthcare IT industry. The industry is typically shielded from macro uncertainty, but tariffs and concerns around an economic slowdown have created broader market uncertainty, which is never good for a high-beta highly volatile group like HCIT/Digital Health/Payviders, the analyst tells investors in a research note. Truist adds that while HCIT companies may not be directly exposed to new tariffs, several of these companies serve end markets - hospitals, pharma, etc. - which are likely to see either some direct impact on their supply chain costs or could decide to slow down on their investments.
Barclays
Andrew Mok
Hold
Maintains
$21 → $23
2025-04-10
Reason
Barclays
Andrew Mok
Price Target
$21 → $23
2025-04-10
Maintains
Hold
Reason
Barclays raised the firm's price target on Privia Health to $23 from $21 and keeps an Equal Weight rating on the shares as part of a Q1 earnings preview for the managed care space.
Needham
Ryan MacDonald
Strong Buy
Reiterates
$30
2025-03-21
Reason
Needham
Ryan MacDonald
Price Target
$30
2025-03-21
Reiterates
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Privia Health Group Inc (PRVA.O) is 102.04, compared to its 5-year average forward P/E of 41.66. For a more detailed relative valuation and DCF analysis to assess Privia Health Group Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
41.66
Current PE
102.04
Overvalued PE
361.69
Undervalued PE
-278.37
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Fair
5Y Average EV/EBITDA
39.34
Current EV/EBITDA
23.39
Overvalued EV/EBITDA
60.55
Undervalued EV/EBITDA
18.13
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
2.04
Current PS
1.56
Overvalued PS
2.95
Undervalued PS
1.12
Financials
Annual
Quarterly
FY2025Q1
YoY :
+15.62%
480.10M
Total Revenue
FY2025Q1
YoY :
+16.57%
7.22M
Operating Profit
FY2025Q1
YoY :
+97.84%
6.05M
Net Income after Tax
FY2025Q1
YoY :
+50.00%
0.03
EPS - Diluted
FY2025Q1
YoY :
-27.39%
-24.06M
Free Cash Flow
FY2025Q1
YoY :
-2.77%
9.14
Gross Profit Margin - %
FY2025Q1
YoY :
+81.99%
6.57
FCF Margin - %
FY2025Q1
YoY :
+70.27%
1.26
Net Margin - %
FY2025Q1
YoY :
-26.42%
2.34
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
2.7M
USD
14
3-6
Months
0.0
USD
0
6-9
Months
2.5M
USD
1
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
1
6.0K
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
800.0K
Volume
2
Bought
0-3
0
0.0
Volume
Months
3-6
1
378.3K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
2.7M
USD
14
3-6
Months
0.0
USD
0
6-9
Months
2.5M
USD
1
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
1
6.0K
USD
Months
PRVA News & Events
Events Timeline
2025-05-08 (ET)
2025-05-08
06:10:54
Privia Health sees FY25 revenue at mid to high end of $1.8B-$1.9B range
2025-05-08
06:09:29
Privia Health reports Q1 adjusted EPS 22c, consensus 18c
2025-04-17 (ET)
2025-04-17
14:37:35
MCOs' 'mixed messages' creating volatility in value-based care, says Truist
Sign Up For More Events
Sign Up For More Events
News
4.0
04-20Business InsiderTruist Financial Sticks to Their Buy Rating for Privia Health Group (PRVA)
4.0
04-15BenzingaAssessing Privia Health Gr: Insights From 10 Financial Analysts
6.0
04-10BenzingaBarclays Maintains Equal-Weight on Privia Health Gr, Raises Price Target to $23
Sign Up For More News
People Also Watch
CWT
California Water Service Group
47.700
USD
+3.25%
KYMR
Kymera Therapeutics Inc
30.250
USD
+0.77%
EQX
Equinox Gold Corp
5.970
USD
-1.16%
LIVN
LivaNova PLC
44.400
USD
+1.32%
MCY
Mercury General Corp
61.770
USD
-0.34%
JBLU
JetBlue Airways Corp
5.070
USD
+3.05%
GRBK
Green Brick Partners Inc
63.050
USD
+2.06%
FCPT
Four Corners Property Trust Inc
27.570
USD
+0.80%
AESI
Atlas Energy Solutions Inc
13.480
USD
+5.56%
STNG
Scorpio Tankers Inc
42.070
USD
+0.91%
FAQ
What is Privia Health Group Inc (PRVA) stock price today?
The current price of PRVA is 25.02 USD — it has increased 0.48 % in the last trading day.
What is Privia Health Group Inc (PRVA)'s business?
What is the price predicton of PRVA Stock?
What is Privia Health Group Inc (PRVA)'s revenue for the last quarter?
What is Privia Health Group Inc (PRVA)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Privia Health Group Inc (PRVA)'s fundamentals?
How many employees does Privia Health Group Inc (PRVA). have?